Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
作者： Luke Lairson , Costas Lyssiotis , Vishal Deshmukh , Peter Schultz
DOI:
关键词:
摘要: The present invention provides methods of inducing differentiation oligodendrocyte progenitor cells to a mature myelinating cell fate with neurotransmitter receptor modulating agent. also stimulating increased myelination in subject need thereof by administering said Methods treating having demyelinating disease using agent are provided.
lens.org 参考文章(101)
James P. Gosling, Immunoassays : a practical approach Oxford University Press. ,(2000)
Donald W. Landry, Donald F. Klein, Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam ,(1999)
Bonnie Davis, Madeleine M. Joullie, Galanthamine derivatives for treatment of alzheimer's disease ,(1995)
Valerio Magnaghi, Patrizia Procacci, Ada Maria Tata, Chapter 15: Novel pharmacological approaches to Schwann cells as neuroprotective agents for peripheral nerve regeneration. International Review of Neurobiology. ,vol. 87, pp. 295- 315 ,(2009) , 10.1016/S0074-7742(09)87015-3
Barbara J. Gour, James Matthew Symonds, Orest W. Blaschuk, Compounds and methods for modulating tissue permeability ,(1997)
Douglas Joseph Dobrozsi, Oral liquid mucoadhesive compositions ,(1999)
Fadi Ragheb, Eduardo Molina-Holgado, Qiao-Ling Cui, Amani Khorchid, Hsueh-Ning Liu, Jorge N. Larocca, Guillermina Almazan, Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes. Journal of Neurochemistry. ,vol. 77, pp. 1396- 1406 ,(2001) , 10.1046/J.1471-4159.2001.00356.X
Alfonso R. Gennaro, Remington: The Science and Practice of Pharmacy ,(2003)
Hardman JG Ed, Goodman & Gilman's The Pharmacological Basis of Therapeutics ,(1985)
Jörg Ogorka, Satish Chandra Khanna, Oskar Kalb, Rajen Shah, Controlled release oral compositions comprising rivastigmine ,(2002)